Quick Takeaways
- WASATCH ADVISORS LP filed SCHEDULE 13G for Journey Medical Corp Common Stock (DERM).
- Disclosed ownership: 5.4%.
- Date of event: 31 Mar 2025.
WASATCH ADVISORS LP - 31 Mar 2025 SCHEDULE 13G Report for Journey Medical Corp Common Stock (DERM)
- Filing Manager
- WASATCH ADVISORS LP
- Reporting Manager
- WASATCH ADVISORS LP
- Security
- Journey Medical Corp Common Stock
- Symbol
- DERM
- Shares outstanding
- 17,233,389 shares
- Disclosed Ownership
- 930,603 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 13 May 2025, 16:10:40 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WASATCH ADVISORS LP disclosed 5.4% ownership in Journey Medical Corp Common Stock (DERM) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 5.4% | 930,603 | 845,277 | 0 | Mikes Yeates | CEO |